Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101630 · ClinicalTrials.gov registry record
Activity Monitoring in Pulmonary Hypertension
A clinical trial of Pulmonary Hypertension, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 230
- Enrollment target
- 1
- Study location
NCT04101630 is a study of Pulmonary Hypertension that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 230 participants, below the 610-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04101630, a study of Pulmonary Hypertension, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, longitudinal, observational study of free-living activity trackers and patient reported outcomes to test the hypothesis that daily activity will have stronger prognostic value than 6MWD in patients with pulmonary hypertension after 12 weeks.
Conditions Studied
Interventions
- BEHAVIORAL Activity Monitoring
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04101630
The ClinicalTrials.gov registry entry for NCT04101630 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 610-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (62% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Activity Monitoring is the first listed.
NCT04101630 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04101630 about?
NCT04101630 is a clinical study titled "Activity Monitoring in Pulmonary Hypertension". This is a prospective, longitudinal, observational study of free-living activity trackers and patient reported outcomes to test the hypothesis that daily activity will have stronger prognostic value than 6MWD in patients with pulmonary hypertension after 12 weeks.
What is the current status of trial NCT04101630?
This trial is currently active not recruiting. The enrollment target is 230 participants. The study started on 2019-10-24. Estimated completion is 2028-01.
What conditions does trial NCT04101630 study?
This clinical trial studies the following conditions: Pulmonary Hypertension.
What interventions are being tested in trial NCT04101630?
The interventions under investigation include: Activity Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT04101630?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04101630 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.